Global medical giants set to open production facilities in Kazakhstan
Ultrasound machines and computer tomographs are set to be manufactured in Kazakhstan. A global leader in the production of medical equipment and digital solutions for healthcare systems plans to establish a plant in the country. The corresponding agreement was reached during the visit of Kazakh President Kassym-Jomart Tokayev to the U.S. Additionally, a framework document signed between the parties encompasses other priority areas of the healthcare industry. A number of joint investment projects are planned to be implemented as part of the long-term cooperation.
“This framework agreement consists of four main parts, covering the establishment of local production on the territory of Kazakhstan, the expansion of service support, training programs, and assistance in the digitalization of medical infrastructure,” said Elena Legezina, President and CEO of GE Healthcare in Russia/CIS.
The Pfizer company is also interested in manufacturing its products in Kazakhstan. One of the world's largest pharmaceutical corporations has announced its readiness to build a pharmaceutical plant in the country. According to Kazakh Health Minister Azhar Giniyat, the primary focus of the new facility will be on vaccine production.
“The project involves establishing a pharmaceutical plant in Kazakhstan to produce a vaccine against pneumococcal disease. This represents a highly effective preventive measure for lung illnesses. The vaccine is administered to young children to prevent pneumonia and also to the elderly, especially those with lung disorders, to prevent the exacerbation of their conditions,” Giniyat said.